Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Int J Mol Sci
2023 Jul 30;2415:. doi: 10.3390/ijms241512202.
Show Gene links
Show Anatomy links
Parkinson's Disease and the Heart: Studying Cardiac Metabolism in the 6-Hydroxydopamine Model.
Silva da Fonsêca V
,
Goncalves VC
,
Augusto Izidoro M
,
Guimarães de Almeida AC
,
Luiz Affonso Fonseca F
,
Alexandre Scorza F
,
Finsterer J
,
Scorza CA
.
Abstract
Parkinson's-disease (PD) is an incurable, age-related neurodegenerative disease, and its global prevalence of disability and death has increased exponentially. Although motor symptoms are the characteristic manifestations of PD, the clinical spectrum also contains a wide variety of non-motor symptoms, which are the main cause of disability and determinants of the decrease in a patient's quality of life. Noteworthy in this regard is the stress on the cardiac system that is often observed in the course of PD; however, its effects have not yet been adequately researched. Here, an untargeted metabolomics approach was used to assess changes in cardiac metabolism in the 6-hydroxydopamine model of PD. Beta-sitosterol, campesterol, cholesterol, monoacylglycerol, α-tocopherol, stearic acid, beta-glycerophosphoric acid, o-phosphoethanolamine, myo-inositol-1-phosphate, alanine, valine and allothreonine are the metabolites that significantly discriminate parkinsonian rats from sham counterparts. Upon analysis of the metabolic pathways with the aim of uncovering the main biological pathways involved in concentration patterns of cardiac metabolites, the biosynthesis of both phosphatidylethanolamine and phosphatidylcholine, the glucose-alanine cycle, glutathione metabolism and plasmalogen synthesis most adequately differentiated sham and parkinsonian rats. Our results reveal that both lipid and energy metabolism are particularly involved in changes in cardiac metabolism in PD. These results provide insight into cardiac metabolic signatures in PD and indicate potential targets for further investigation.
Bachhawat,
The glutathione cycle: Glutathione metabolism beyond the γ-glutamyl cycle.
2018, Pubmed
Bachhawat,
The glutathione cycle: Glutathione metabolism beyond the γ-glutamyl cycle.
2018,
Pubmed
Badanjak,
The Contribution of Microglia to Neuroinflammation in Parkinson's Disease.
2021,
Pubmed
Bargui,
Phospholipids: Identification and Implication in Muscle Pathophysiology.
2021,
Pubmed
Bjørklund,
The glutathione system in Parkinson's disease and its progression.
2021,
Pubmed
Bloem,
Parkinson's disease.
2021,
Pubmed
Bodine,
An American Physiological Society cross-journal Call for Papers on "Inter-Organ Communication in Homeostasis and Disease".
2021,
Pubmed
Bozelli,
Plasmalogens and Chronic Inflammatory Diseases.
2021,
Pubmed
Buergel,
Metabolomic profiles predict individual multidisease outcomes.
2022,
Pubmed
Calzada,
Phosphatidylethanolamine Metabolism in Health and Disease.
2016,
Pubmed
Cestari,
Phosphoinositide signaling and regulation in Trypanosoma brucei: Specialized functions in a protozoan pathogen.
2020,
Pubmed
Charisis,
Plasma Glutathione and Prodromal Parkinson's Disease Probability.
2022,
Pubmed
Chatree,
Role of Inositols and Inositol Phosphates in Energy Metabolism.
2020,
Pubmed
Chhetri,
Myo-Inositol and Its Derivatives: Their Emerging Role in the Treatment of Human Diseases.
2019,
Pubmed
Deng,
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders.
2020,
Pubmed
Duan,
Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics.
2022,
Pubmed
Fisher,
Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance.
2002,
Pubmed
Ge,
Phytosterol accumulation results in ventricular arrhythmia, impaired cardiac function and death in mice.
2021,
Pubmed
Glatz,
Re-balancing cellular energy substrate metabolism to mend the failing heart.
2020,
Pubmed
Gomes,
Glucose Homeostasis Is Not Affected in a Murine Model of Parkinson's Disease Induced by 6-OHDA.
2018,
Pubmed
Gonzalez-Uarquin,
Myo-inositol: its metabolism and potential implications for poultry nutrition-a review.
2020,
Pubmed
Gopinath,
The complex role of inflammation and gliotransmitters in Parkinson's disease.
2023,
Pubmed
Gödecke,
Intra- and Interorgan Communication in the Cardiovascular System: A Special View on Redox Regulation.
2017,
Pubmed
Harper,
Branched-chain amino acid metabolism.
1984,
Pubmed
Hou,
Ageing as a risk factor for neurodegenerative disease.
2019,
Pubmed
Ilaiwy,
Human amylin proteotoxicity impairs protein biosynthesis, and alters major cellular signaling pathways in the heart, brain and liver of humanized diabetic rat model in vivo.
2016,
Pubmed
Kennergren,
Extracellular amino acids as markers of myocardial ischemia during cardioplegic heart arrest.
1999,
Pubmed
Koundouros,
Reprogramming of fatty acid metabolism in cancer.
2020,
Pubmed
Kumari,
Metabolomic analysis of serum using proton NMR in 6-OHDA experimental PD model and patients with PD.
2020,
Pubmed
Li,
The Bioavailability and Biological Activities of Phytosterols as Modulators of Cholesterol Metabolism.
2022,
Pubmed
Lopaschuk,
Cardiac Energy Metabolism in Heart Failure.
2021,
Pubmed
Lu,
Glutathione synthesis.
2013,
Pubmed
Luo,
Mechanisms and regulation of cholesterol homeostasis.
2020,
Pubmed
MacMahon Copas,
The Pathogenesis of Parkinson's Disease: A Complex Interplay Between Astrocytes, Microglia, and T Lymphocytes?
2021,
Pubmed
Mastrangelo,
From sample treatment to biomarker discovery: A tutorial for untargeted metabolomics based on GC-(EI)-Q-MS.
2015,
Pubmed
Mischley,
Glutathione as a Biomarker in Parkinson's Disease: Associations with Aging and Disease Severity.
2016,
Pubmed
Ou,
Global Trends in the Incidence, Prevalence, and Years Lived With Disability of Parkinson's Disease in 204 Countries/Territories From 1990 to 2019.
2021,
Pubmed
Pajares,
Inflammation in Parkinson's Disease: Mechanisms and Therapeutic Implications.
2020,
Pubmed
Park,
Lipids in the heart: a source of fuel and a source of toxins.
2007,
Pubmed
Patel,
Ethanolamine and Phosphatidylethanolamine: Partners in Health and Disease.
2017,
Pubmed
Paulusma,
Amino acid metabolism, transport and signalling in the liver revisited.
2022,
Pubmed
Perlbarg,
Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson's disease evaluated with multimodal MRI.
2018,
Pubmed
Poewe,
Parkinson disease.
2017,
Pubmed
Poli,
Phytosterols, Cholesterol Control, and Cardiovascular Disease.
2021,
Pubmed
Poursharifi,
Monoacylglycerol signalling and ABHD6 in health and disease.
2017,
Pubmed
Qian,
Comprehensive metabolomic and lipidomic alterations in response to heat stress during seed germination and seedling growth of Arabidopsis.
2023,
Pubmed
Qiu,
Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson's disease.
2022,
Pubmed
Ragni,
Dietary essential amino acids for the treatment of heart failure with reduced ejection fraction.
2023,
Pubmed
Ranea-Robles,
A mitochondrial long-chain fatty acid oxidation defect leads to transfer RNA uncharging and activation of the integrated stress response in the mouse heart.
2022,
Pubmed
Rong,
Cardioprotective Mechanism of Leonurine against Myocardial Ischemia through a Liver-Cardiac Crosstalk Metabolomics Study.
2022,
Pubmed
Sarabhai,
Hungry for your alanine: when liver depends on muscle proteolysis.
2019,
Pubmed
Scholz,
Genome-wide meta-analysis of phytosterols reveals five novel loci and a detrimental effect on coronary atherosclerosis.
2022,
Pubmed
Shah,
Palmitate and Stearate are Increased in the Plasma in a 6-OHDA Model of Parkinson's Disease.
2019,
Pubmed
Shao,
Recent advances and perspectives of metabolomics-based investigations in Parkinson's disease.
2019,
Pubmed
She,
Targeting amino acids metabolic profile to identify novel metabolic characteristics in atrial fibrillation.
2018,
Pubmed
Shimohama,
Disease model: Parkinson's disease.
2003,
Pubmed
Tavasoli,
Genetic diseases of the Kennedy pathways for membrane synthesis.
2020,
Pubmed
Tini,
Alzheimer's Disease and Cardiovascular Disease: A Particular Association.
2020,
Pubmed
Toczylowska,
Changes in the metabolic profiles of the serum and putamen in Parkinson's disease patients - In vitro and in vivo NMR spectroscopy studies.
2020,
Pubmed
Tu-Sekine,
The Inositol Phosphate System-A Coordinator of Metabolic Adaptability.
2022,
Pubmed
Wundenberg,
Synthesis and biological actions of diphosphoinositol phosphates (inositol pyrophosphates), regulators of cell homeostasis.
2012,
Pubmed
Xicoy,
The Role of Lipids in Parkinson's Disease.
2019,
Pubmed
Yang,
Lipid metabolism and storage in neuroglia: role in brain development and neurodegenerative diseases.
2022,
Pubmed
Yoon,
Lipid metabolism in sickness and in health: Emerging regulators of lipotoxicity.
2021,
Pubmed
Zampelas,
New Insights into Cholesterol Functions: A Friend or an Enemy?
2019,
Pubmed
Zhang,
The Mechanism and Function of Glia in Parkinson's Disease.
2022,
Pubmed
Zhou,
Advances in the Biosynthetic Pathways and Application Potential of Plasmalogens in Medicine.
2020,
Pubmed
Zhu,
Metabolomic Analysis of Plasma From Patients With Acute Mountain Sickness Using Chromatography-Mass Spectrometry.
2015,
Pubmed
van der Veen,
The concentration of phosphatidylethanolamine in mitochondria can modulate ATP production and glucose metabolism in mice.
2014,
Pubmed
van der Veen,
The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease.
2017,
Pubmed
